发明授权
US08404848B2 Derivatives of imidazo[1,2-a]pyridine-2-carboxamides, preparation method thereof and use of same in therapeutics
有权
咪唑并[1,2-a]吡啶-2-甲酰胺的衍生物，其制备方法及其在治疗中的应用
![Derivatives of imidazo[1,2-a]pyridine-2-carboxamides, preparation method thereof and use of same in therapeutics](/docs/US/2013-03-26/US08404848B2/abs.jpg.600x600.jpg)
- 专利标题： Derivatives of imidazo[1,2-a]pyridine-2-carboxamides, preparation method thereof and use of same in therapeutics
- 专利标题（中）： 咪唑并[1,2-a]吡啶-2-甲酰胺的衍生物，其制备方法及其在治疗中的应用
-
申请号： US12711779申请日： 2010-02-24
-
公开(公告)号： US08404848B2公开(公告)日： 2013-03-26
- 发明人: Youssed El-Ahmad , Anne Olivier , Jean-Francois Peyronel
- 申请人： Youssed El-Ahmad , Anne Olivier , Jean-Francois Peyronel
- 申请人地址： FR Paris
- 专利权人： Sanofi
- 当前专利权人： Sanofi
- 当前专利权人地址： FR Paris
- 代理机构： Scully, Scott, Murphy & Presser, P.C.
- 优先权： FR0606012 20060703
- 主分类号： C07D471/04
- IPC分类号： C07D471/04 ; A61K31/437 ; A61P25/28
![Derivatives of imidazo[1,2-a]pyridine-2-carboxamides, preparation method thereof and use of same in therapeutics](/abs-image/US/2013/03/26/US08404848B2/abs.jpg.150x150.jpg)
摘要：
The present invention is related to a compound of formula (I): wherein R1, R2, R3, R4 and X are as defined herein, or an addition salt with an acid thereof, its pharmaceutical composition or use for treating or preventing diseases involving Nurr-1 nuclear receptors, also known as NR4A2, NOT, TINUR, RNR-1 and HZF3.
公开/授权文献
信息查询
